Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Axogen (AXGN) EBIT (2016 - 2025)

Axogen (AXGN) has 16 years of EBIT data on record, last reported at -$9.8 million in Q4 2025.

  • For Q4 2025, EBIT fell 584.48% year-over-year to -$9.8 million; the TTM value through Dec 2025 reached -$7.8 million, down 138.79%, while the annual FY2025 figure was -$7.8 million, 138.79% down from the prior year.
  • EBIT reached -$9.8 million in Q4 2025 per AXGN's latest filing, down from $1.9 million in the prior quarter.
  • Across five years, EBIT topped out at $2.0 million in Q4 2024 and bottomed at -$11.3 million in Q1 2022.
  • Average EBIT over 5 years is -$4.4 million, with a median of -$5.1 million recorded in 2021.
  • The widest YoY moves for EBIT: up 705.06% in 2025, down 584.48% in 2025.
  • A 5-year view of EBIT shows it stood at -$5.4 million in 2021, then dropped by 4.76% to -$5.6 million in 2022, then skyrocketed by 43.05% to -$3.2 million in 2023, then surged by 163.15% to $2.0 million in 2024, then plummeted by 584.48% to -$9.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were -$9.8 million in Q4 2025, $1.9 million in Q3 2025, and $1.7 million in Q2 2025.